Bausch + Lomb Announces Statistically Significant Topline Results from Second Phase 3 Trial of NOV03
Wednesday, October 6 2021 | 11 h 29 min | News, Press Release
Bausch + Lomb and Novaliq announced statistically significant topline data from the second Phase 3 (MOJAVE) trial evaluating the investigational...
Read MoreCooperVision: SightGlass Vision Diffusion Optics Technology Demonstrates Significant Reduction in Myopia Progression
Wednesday, October 6 2021 | 11 h 27 min | News, Press Release
CooperVision’s SightGlass Vision Business has revealed two-year clinical study data for its Diffusion Optics Technology™, which is specifically...
Read MoreChanging Landscapes – Selling & Buying a Practice
Wednesday, October 6 2021 | 07 h 36 min | Events, News, Press Release
The second event of the “Changing Landscapes: Opportunities & Options for Canadian ECPs will focus on Selling & Buying a Practice and will...
Read MoreItalian Eyewear Expects Full Recovery to Pre-pandemic Levels in 2021
Tuesday, October 5 2021 | 14 h 04 min | Financial News, News, Press Release
ANFAO ( Associazione Nazionale Fabbricanti Articoli Ottici) - the Italian National Association of Optical Goods Manufacturers - reports...
Read MoreEssilorLuxottica’s Breakthrough Innovations Showcased and Awarded at SILMO 2021
Friday, October 1 2021 | 16 h 01 min | Awards, News, Press Release
EssilorLuxottica was recognized with a “Silmo d’Or” award for its latest breakthrough innovation, Transitions XTRActive...
Read More